Stock Analysis

Does Universal Health Services Still Offer Value After Its 2024 Rally and Recent Pullback?

  • If you have been wondering whether Universal Health Services is still a buy after its strong run, you are not alone. This article explores what the current price might really be baking in.
  • The stock has climbed 32.8% year to date and 20.4% over the last year, even after a recent 2.3% pullback this week. This suggests investors are reassessing both its growth potential and its risk profile.
  • Part of that momentum reflects ongoing interest in behavioral health and acute care capacity in the US, as hospitals and payors lean on large operators like UHS for scale and stability. At the same time, headlines around healthcare policy, reimbursement dynamics, and shifting demand for mental health services have kept the stock on many investors’ radars as a barometer for the broader sector.
  • On our checks, Universal Health Services scores a solid 5/6 valuation score, suggesting it looks undervalued on most metrics. Next, we will walk through the key valuation approaches investors typically use, before finishing with a more holistic way to think about what this business is really worth.

Universal Health Services delivered 20.4% returns over the last year. See how this stacks up to the rest of the Healthcare industry.

Advertisement

Approach 1: Universal Health Services Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a company is worth by forecasting its future cash flows and then discounting them back to today, using a required rate of return. For Universal Health Services, the model starts with last twelve month Free Cash Flow of about $1.0 billion and projects this rising steadily over time as the hospital portfolio expands and margins improve.

Analyst and internal projections see Free Cash Flow reaching roughly $1.77 billion by 2035, with growth gradually slowing from the mid single digits as the business matures. Simply Wall St uses a 2 stage Free Cash Flow to Equity framework, combining these yearly forecasts with a long term terminal value to arrive at an intrinsic value of about $569.48 per share.

Compared with the current share price, this implies the stock is about 58.1% undervalued on a cash flow basis, which indicates the market may be overly cautious about long term reimbursement and demand risks.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Universal Health Services is undervalued by 58.1%. Track this in your watchlist or portfolio, or discover 925 more undervalued stocks based on cash flows.

UHS Discounted Cash Flow as at Dec 2025
UHS Discounted Cash Flow as at Dec 2025

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Universal Health Services.

Approach 2: Universal Health Services Price vs Earnings

For a consistently profitable business like Universal Health Services, the Price to Earnings (PE) ratio is a useful way to judge how much investors are paying for each dollar of current earnings. In general, faster growth and lower perceived risk can justify a higher PE, while slower growth or higher uncertainty typically lead to a lower, more conservative multiple.

Universal Health Services currently trades at about 10.84x earnings, which is well below the broader Healthcare industry average of roughly 22.14x and the peer group average of about 24.01x. Simply Wall St also calculates a Fair Ratio of 23.29x for Universal Health Services, which is the PE level the company might reasonably command given its earnings growth outlook, profitability, size, industry positioning, and risk profile.

This Fair Ratio is more informative than a simple industry or peer comparison because it explicitly adjusts for Universal Health Services specific fundamentals rather than assuming it should trade in line with a broad group. Comparing the current 10.84x PE to the Fair Ratio of 23.29x indicates that the market is assigning a sizeable discount to the stock on an earnings basis.

Result: UNDERVALUED

NYSE:UHS PE Ratio as at Dec 2025
NYSE:UHS PE Ratio as at Dec 2025

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1441 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Universal Health Services Narrative

Earlier we mentioned that there is an even better way to understand valuation. Let us introduce you to Narratives, an approach where you combine your view of Universal Health Services future revenue, earnings, and margins with a clear story about its business. The platform automatically links that story to a financial forecast, a fair value, and an easy buy or sell signal by comparing that fair value to the current price, updating dynamically as new news or earnings arrive, all within the Simply Wall St Community page that millions of investors already use. One investor might build a more optimistic Universal Health Services Narrative around accelerating behavioral health demand, margin expansion, and steady policy support that justifies a fair value closer to the bullish 280 dollars target. Another might focus on reimbursement cuts, labor pressures, and competitive threats that anchor their Narrative near the more cautious 165 dollars view. Both can quickly see how their assumptions translate into numbers and what that implies for their next move.

Do you think there's more to the story for Universal Health Services? Head over to our Community to see what others are saying!

NYSE:UHS Community Fair Values as at Dec 2025
NYSE:UHS Community Fair Values as at Dec 2025

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:UHS

Universal Health Services

Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities.

Undervalued with solid track record.

Advertisement

Weekly Picks

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
21 users have followed this narrative
6 users have commented on this narrative
5 users have liked this narrative
RO
Robbo
FID logo
Robbo on Fiducian Group ·

Fiducian: Compliance Clouds or Value Opportunity?

Fair Value:AU$126.1% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
WVVI logo
woodworthfund on Willamette Valley Vineyards ·

Willamette Valley Vineyards (WVVI): Not-So-Great Value

Fair Value:US$242.5% overvalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

MA
MarkoVT
GOOGL logo
MarkoVT on Alphabet ·

Positioned globally, partnered locally

Fair Value:US$390.1919.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JO
JohnJ
WLN logo
JohnJ on Worldline ·

When will fraudsters be investigated in depth. Fraud was ongoing in France too.

Fair Value:€0.5200.8% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
MarkoVT
APLD logo
MarkoVT on Applied Digital ·

Staggered by dilution; positions for growth

Fair Value:US$35.4520.9% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.6% undervalued
112 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.5% undervalued
949 users have followed this narrative
6 users have commented on this narrative
24 users have liked this narrative
OS
oscargarcia
GOOGL logo
oscargarcia on Alphabet ·

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

Fair Value:US$3407.1% undervalued
148 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative